A detailed history of Heck Capital Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Heck Capital Advisors, LLC holds 3,106 shares of NVS stock, worth $359,550. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,106
Holding current value
$359,550
% of portfolio
0.04%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$97.14 - $115.57 $301,716 - $358,960
3,106 New
3,106 $346 Million
Q4 2024

May 13, 2025

SELL
$96.78 - $117.18 $387 - $468
-4 Reduced 0.13%
3,102 $302 Million
Q4 2024

Jan 23, 2025

BUY
$96.78 - $117.18 $322,374 - $390,326
3,331 New
3,331 $324 Million
Q3 2024

May 19, 2025

SELL
$106.13 - $120.89 $347,045 - $395,310
-3,270 Reduced 51.29%
3,106 $357 Million
Q2 2024

May 19, 2025

BUY
$92.57 - $107.37 $296,038 - $343,369
3,198 Added 100.63%
6,376 $679 Million
Q1 2024

May 19, 2025

SELL
$95.27 - $108.47 $3,810 - $4,338
-40 Reduced 1.24%
3,178 $307 Million
Q4 2023

May 19, 2025

SELL
$92.27 - $101.54 $26,573 - $29,243
-288 Reduced 8.21%
3,218 $325 Million
Q3 2023

May 19, 2025

BUY
$94.73 - $105.13 $37,892 - $42,052
400 Added 12.88%
3,506 $357 Million
Q2 2023

May 19, 2025

SELL
$92.52 - $104.91 $7,956 - $9,022
-86 Reduced 2.36%
3,551 $358 Million
Q1 2023

May 19, 2025

BUY
$80.03 - $92.81 $10,323 - $11,972
129 Added 3.68%
3,637 $335 Million
Q4 2022

May 19, 2025

BUY
$75.55 - $92.52 $24,931 - $30,531
330 Added 10.38%
3,508 $318 Million
Q3 2022

May 20, 2025

BUY
$74.61 - $87.26 $26,113 - $30,541
350 Added 11.27%
3,456 $263 Million
Q3 2022

May 19, 2025

SELL
$74.61 - $87.26 $16,190 - $18,935
-217 Reduced 6.39%
3,178 $307 Million
Q2 2022

May 19, 2025

SELL
$80.52 - $93.75 $33,415 - $38,906
-415 Reduced 10.89%
3,395 $287 Million
Q1 2022

May 19, 2025

BUY
$80.11 - $90.62 $56,397 - $63,796
704 Added 22.67%
3,810 $334 Million
Q4 2021

May 19, 2025

SELL
$79.7 - $88.13 $21,997 - $24,323
-276 Reduced 6.69%
3,849 $337 Million
Q3 2021

May 19, 2025

SELL
$81.78 - $95.14 $5,479 - $6,374
-67 Reduced 1.6%
4,125 $337 Million
Q2 2021

May 19, 2025

BUY
$85.24 - $94.15 $32,561 - $35,965
382 Added 10.03%
4,192 $382 Million
Q1 2021

May 19, 2025

SELL
$83.5 - $98.47 $35,571 - $41,948
-426 Reduced 10.06%
3,810 $334 Million
Q4 2020

May 19, 2025

SELL
$78.07 - $94.43 $546 - $661
-7 Reduced 0.16%
4,236 $400 Million
Q3 2020

May 19, 2025

BUY
$82.14 - $91.0 $93,393 - $103,467
1,137 Added 36.61%
4,243 $369 Million
Q2 2020

May 19, 2025

BUY
$80.93 - $91.1 $74,698 - $84,085
923 Added 30.82%
3,918 $342 Million
Q1 2020

May 19, 2025

SELL
$70.67 - $99.01 $6,572 - $9,207
-93 Reduced 3.01%
2,995 $247 Million
Q4 2019

May 19, 2025

BUY
$84.35 - $95.37 $9,447 - $10,681
112 Added 3.76%
3,088 $292 Million
Q3 2019

May 19, 2025

BUY
$85.54 - $94.26 $9,922 - $10,934
116 Added 4.06%
2,976 $259 Million
Q2 2019

May 19, 2025

BUY
$75.4 - $92.8 $8,444 - $10,393
112 Added 4.08%
2,860 $261 Million
Q1 2019

May 19, 2025

SELL
$75.32 - $86.15 $26,964 - $30,841
-358 Reduced 11.53%
2,748 $264 Million
Q4 2018

May 19, 2025

SELL
$73.66 - $82.02 $3,830 - $4,265
-52 Reduced 1.93%
2,643 $227 Million
Q3 2018

May 19, 2025

SELL
$66.94 - $77.43 $11,446 - $13,240
-171 Reduced 5.97%
2,695 $232 Million
Q2 2018

May 19, 2025

BUY
$64.91 - $73.36 $1,168 - $1,320
18 Added 0.63%
2,866 $216 Million
Q1 2018

May 19, 2025

SELL
$70.39 - $84.15 $422 - $504
-6 Reduced 0.21%
2,848 $230 Million
Q4 2017

May 19, 2025

BUY
$72.33 - $77.64 $1,591 - $1,708
22 Added 0.78%
2,854 $240 Million
Q3 2017

May 19, 2025

BUY
$74.14 - $77.27 $6,153 - $6,413
83 Added 3.02%
2,832 $243 Million
Q2 2017

May 19, 2025

SELL
N/A
-204 Reduced 6.91%
2,749 $229 Million
Q1 2017

May 19, 2025

SELL
N/A
-153 Reduced 4.93%
2,953 $219 Million
Q4 2016

May 19, 2025

SELL
N/A
-13
3,093 $225 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Heck Capital Advisors, LLC Portfolio

Follow Heck Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heck Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heck Capital Advisors, LLC with notifications on news.